Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free
Close

Gilead Sciences Inc (GILD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
64.79 -0.20    -0.31%
23/09 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 10,241
  • Bid/Ask: 64.79 / 64.86
  • Day's Range: 64.44 - 65.54
Type:  Equity
Market:  Germany
ISIN:  US3755581036 
S/N:  885823
Gilead 64.79 -0.20 -0.31%

GILD Technical Analysis

 
Gilead share technical analysis data, signals range from strong buy, buy, neutral, sell to strong Sell. Assess a detailed technical analysis based on the buy/sell signals of moving averages (simple and exponential for a wide range of periods) and buy, sell, overbought, oversold or neutral signals of common chart indicators (including RSI, MACD and CCI). View the GILD stock analysis data across your chosen time frame.
Summary:Strong Sell
Moving Averages:Strong SellBuy (2)Sell (10)
Technical Indicators:Strong SellBuy (1)Sell (9)

Pivot PointsSep 23, 2022 20:56 GMT

Name S3 S2 S1 Pivot Points R1 R2 R3
Classic 64.30 64.37 64.50 64.57 64.70 64.77 64.90
Fibonacci 64.37 64.45 64.49 64.57 64.65 64.69 64.77
Camarilla 64.59 64.60 64.62 64.57 64.66 64.68 64.69
Woodie's 64.34 64.39 64.54 64.59 64.74 64.79 64.94
DeMark's - - 64.54 64.59 64.74 - -

Technical IndicatorsSep 23, 2022 20:56 GMT

Name Value Action
RSI(14) 47.734 Neutral
STOCH(9,6) 28.006 Sell
STOCHRSI(14) 31.612 Sell
MACD(12,26) -0.100 Sell
ADX(14) 32.715 Buy
Williams %R -68.182 Sell
CCI(14) -75.3095 Sell
ATR(14) 0.3414 High Volatility
Highs/Lows(14) -0.0393 Sell
Ultimate Oscillator 44.232 Sell
ROC -0.308 Sell
Bull/Bear Power(13) -0.2840 Sell

Buy: 1

Sell: 9

Neutral: 1


Summary:Strong Sell

Moving AveragesSep 23, 2022 20:56 GMT

Period Simple Exponential
MA5 64.67
Buy
64.75
Buy
MA10 64.89
Sell
64.83
Sell
MA20 64.92
Sell
64.92
Sell
MA50 65.03
Sell
64.99
Sell
MA100 65.10
Sell
65.05
Sell
MA200 65.07
Sell
64.95
Sell

Buy: 2

Sell: 10


Summary:Strong Sell

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GILD Comments

Write your thoughts about Gilead Sciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oc Masai
Oc Masai Apr 27, 2021 7:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good job GILD. bullish move forward
Ashraf Elgendy
Ashraf Elgendy Mar 07, 2021 13:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Kite, a unit of Gilead Sciences (GILD),has announced that theFDA has granted approval for its T cell immunotherapy Yescarta (axicabtagene ciloleucel) for a certain category of adults...
RM RM
RM RM Mar 01, 2021 21:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Up Again
Ken Laing
Ken Laing Oct 23, 2020 18:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to load up before the big rise coming next week
Iggy Maldon
Iggy Maldon Jul 30, 2020 20:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Classic pump n’ dump. What a shambles
RM RM
RM RM May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will reach above 95
Chili Daug
Chili Daug May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
when? hahah
SAGAR AGARWAL
SAGAR AGARWAL May 15, 2020 14:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good time to accumulate.
Khizer Malik
Khizer Malik May 14, 2020 11:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Gilead will be supplying remdesivir to 127 countries starting next week! Also backed by big government organisations including donald trump. Good investmenr
Willy Chin
Willy Chin Apr 23, 2020 18:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
High chance to be trading above 90, good long stock
Viktor Veselý
Viktor Veselý Apr 12, 2020 7:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
By Deena Beasley(Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc., according to new data based on patient observation.The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included -- in one case because of a dosing error.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email